Professor Emeritus, Osaka University, Suita, Osaka, Japan.
National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Proc Jpn Acad Ser B Phys Biol Sci. 2024;100(8):429-445. doi: 10.2183/pjab.100.027.
In 1935, Shiro Akabori began research on the preparation of taka-amylase A with a purity suitable for chemical research, with the intention of elucidating the chemical nature of the enzyme. He succeeded in developing a method to efficiently obtain crystallized taka-amylase A from Aspergillus oryzae. Using crystallized taka-amylase A as the starting material, a series of studies were conducted to determine its amino acid composition and sequence, sugar chain structure, and three-dimensional structure. Based on these results, the molecular structure and catalytic mechanism of taka-amylase A were elucidated. The scientific achievements from research on taka-amylase A significantly enhanced Japan's capabilities in protein research, represented by the fact that taka-amylase A was the first amylase in the world for which both chemical and crystallographic structures were elucidated.
1935 年,白坂四郎开始研究制备适合化学研究用的高纯度的 taka-amylase A,旨在阐明该酶的化学性质。他成功开发出一种从米曲霉中高效获得结晶 taka-amylase A 的方法。以结晶 taka-amylase A 为起始物质,进行了一系列研究以确定其氨基酸组成和序列、糖链结构和三维结构。基于这些结果,阐明了 taka-amylase A 的分子结构和催化机制。taka-amylase A 的研究成果极大地增强了日本的蛋白质研究能力,这一点体现在 taka-amylase A 是世界上第一个阐明其化学和晶体结构的淀粉酶。